Order Article Reprints

Oweira H, Lahdou I, Mehrle S, Khajeh E, Nikbakhsh R, Ghamarnejad O, Terness P, Reißfelder C, Sadeghi M, Ramouz A. Correction: Oweira et al. Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepaRG Tumor Cells. J. Clin. Med. 2022, 11, 4794. Journal of Clinical Medicine. 2023; 12(9):3177. https://doi.org/10.3390/jcm12093177

Oweira, Hani, Imad Lahdou, Stefan Mehrle, Elias Khajeh, Rajan Nikbakhsh, Omid Ghamarnejad, Peter Terness, Christoph Reißfelder, Mahmoud Sadeghi, and Ali Ramouz. 2023. "Correction: Oweira et al. Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepaRG Tumor Cells. J. Clin. Med. 2022, 11, 4794" Journal of Clinical Medicine 12, no. 9: 3177. https://doi.org/10.3390/jcm12093177

Oweira, H., Lahdou, I., Mehrle, S., Khajeh, E., Nikbakhsh, R., Ghamarnejad, O., Terness, P., Reißfelder, C., Sadeghi, M., & Ramouz, A. (2023). Correction: Oweira et al. Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepaRG Tumor Cells. J. Clin. Med. 2022, 11, 4794. Journal of Clinical Medicine, 12(9), 3177. https://doi.org/10.3390/jcm12093177